CorMedix Insider Exercises Options and Sells Shares—Beneficial Ownership Updated
Rhea-AI Filing Summary
CorMedix Inc. insider Beth Zelnick Kaufman reported multiple transactions on 09/09/2025. She acquired 50,000 shares by exercising options at an exercise price of $3.30 (options originally granted 12/12/2023, vesting over four years). On the same date she disposed of 49,600 shares at a weighted average price of $13.41 and 400 shares at $12.82. Following these trades her beneficial ownership is reported as 180,418 shares.
Positive
- Acquired 50,000 shares by exercising stock options at an exercise price of $3.30 on 09/09/2025
- Options grant disclosed: options were granted on 12/12/2023 and vest over four years in equal instalments
Negative
- Disposed of 50,000 shares on 09/09/2025 (49,600 shares at a weighted average price of $13.41 and 400 shares at $12.82), reducing beneficial ownership from 230,418 to 180,418
- Sales executed across a price range of $12.83 to $13.82 (weighted average reported), indicating multiple trades rather than a single block sale
Insights
TL;DR: Insider exercised options and sold an equal number of shares same day, leaving a net reduction in reported holdings.
The filing shows exercise of 50,000 option-derived shares at $3.30 and near-immediate dispositions totaling 50,000 shares at weighted prices of $12.82–$13.82 (reported weighted average $13.41). The options were granted 12/12/2023 and vest over four years. Reported beneficial ownership after the transactions is 180,418 shares. For investors this is a clear record of non-derivative acquisition via exercise and concurrent market sales; the filing contains precise quantities and prices without further commentary.
TL;DR: Transactions are properly disclosed: option exercise followed by open-market sales, with signature and explanatory footnotes included.
The Form 4 includes required disclosures: transaction codes, exercise price, grant date, vesting schedule, and an explanation that sales executed across prices $12.83–$13.82 with a weighted average reported. The form is signed and dated 09/11/2025. Documentation appears complete for Section 16 reporting; no amendment or missing procedural details are evident in the submitted content.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy Common Stock) | 50,000 | $0.00 | -- |
| Exercise | Common Stock | 50,000 | $3.30 | $165K |
| Sale | Common Stock | 49,600 | $13.41 | $665K |
| Sale | Common Stock | 400 | $12.82 | $5K |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $12.83 to $13.82. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.
